Abstract:Cataract formation is the leading cause of blindness across the globe. The eye lens is the onset site of cataract. The eye lens is densely packed with crystallins at a high concentration. Crystallins are categorized into 3 distinct families: alpha-, beta-, and gamma-CRYs. The alpha-CRYs are known to function as a small molecule chaperone, recognizing misfolded proteins and maintaining protein homeostasis in the lens. While the beta-/gamma-CRYs serve a key structural role in lens formation through intramolecular and intermolecular interactions. Crystallins are arranged in transiently short-range order within the lens fibers. In addition, the molecular recognition and dynamic protein interactions that are medicated by crystallins serve a critical role in maintaining the transparency of the eye lens. Protein homeostasis disorder in eye lens is the main pathogenic factors causing cataract. The crystallins have a long half-life and no longer renewed after protein synthesis. Therefore, the crystallins are highly susceptible to both the extracellular and intracellular factors, such as pH, metal ions, radiation damage and post-translational modifications. These factors disrupt molecular recognition of the crystallins or alter protein-protein interactions, resulting in cataract formation. Identifying the chemical regulatory principles of molecular recognition and protein interactions of the crystallins can help elucidate the molecular mechanisms that maintain or disrupt lens transparency, along with developing innovative treatment strategies for cataract. In this review, based on recent prowess in crystallins and cataracts, we comprehensively summarized the way of molecular recognition and protein interaction in the crystallins, as well as the regulatory factors. Recent technological innovations that were enabling us to characterize interactions between the crystallins were further discussed. In addition, we investigated the application values and challenges of protein-protein interaction networks that were dominated by the crystallins in the anti-cataract drug development.

[Research progress on the relationship between circular RNAs and cataract].

The Potential Role of Circular RNAs in High-Myopic Cataract Suggested by Whole Transcriptome Sequencing

Research Progress of Circular RNA in Ophthalmic Diseases

Noncoding RNAs in Cataract Formation: Star Molecules Emerge in an Endless Stream.

CircRNA is a Rising Star in Researches of Ocular Diseases

Circular Rnas: Novel Promising Biomarkers In Ocular Diseases

CircRNA Expression Profiles and Regulatory Networks in the Vitreous Humor of People with High Myopia.

CircRNA 06209 inhibits cataract development by sponging miR-6848-5p and regulating ALOX15 expression

CircRNA in Ocular Neovascular Diseases: Fundamental Mechanism and Clinical Potential.

Circular RNA Expression and the Competitive Endogenous RNA Network in Pathological, Age-Related Macular Degeneration Events: A Cross-Platform Normalization Study

Circular and long non-coding RNAs and their role in ophthalmologic diseases

Circular RNA and its mechanisms in diabetic retinopathy: a systematic review

The Differential Expression of Circular RNAs and the Role of circAFF1 in Lens Epithelial Cells of High-Myopic Cataract

[Role of microRNA and lncRNA in lens development and cataract formation].

Roles of non-coding RNAs in eye development and diseases.

Circular RNA HIPK3 regulates human lens epithelial cells proliferation and apoptosis by targeting the miR-193a/CRYAA axis

Circular RNAs: Potential Star Molecules Involved in Diabetic Retinopathy

The impact of non-coding RNAs in the pathobiology of eye disorders

Pathogenesis and Prospects for Therapeutic Clinical Application of Noncoding RNAs in Glaucoma: Systematic Perspectives

Roles of non‐coding <scp>RNAs</scp> in eye development and diseases

Research Progress of Molecular Recognition and Interaction of Crystallins Linking Cataract